Maternal Recall of Prescription Medication Use During Pregnancy Using a Paper-Based Questionnaire A Validation Study in The Netherlands

被引:48
|
作者
van Gelder, Marleen M. H. J. [1 ]
van Rooij, Iris A. L. M. [1 ]
de Walle, Hermien E. K. [2 ]
Roeleveld, Nel [1 ]
Bakker, Marian K. [2 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6500 HB Nijmegen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Eurocat Northern Netherlands, Groningen, Netherlands
关键词
DRUG-USE; BIRTH-DEFECTS; PHARMACY RECORDS; MOTHERS; EXPOSURE; BIAS; INFORMATION; DELIVERY; COHORT; WOMEN;
D O I
10.1007/s40264-012-0004-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background In case-control studies that assess associations between medication use and birth defects, detailed information on type of medication and timing of use is essential to prevent misclassification. However, data on the accuracy of recall of medication use during pregnancy are scarce. Objective The aim of this study was to validate a self-administered questionnaire to assess prescription medication use in the 3 months before and during pregnancy. Methods This validation study was embedded in Eurocat Northern Netherlands, a population-based birth defects registry that covers 10 % of all births in The Netherlands. The questionnaire was validated among 560 mothers of infants with major birth defects registered from 1 January 2009 through 30 June 2010 by comparing it with a reference standard consisting of pharmacy data which were checked for compliance by maternal interviews. Sensitivity and specificity were calculated to quantify validity for any prescription medication use, groups of medications and individual medications. In addition, we determined whether maternal characteristics influenced disagreement between the questionnaire and the reference standard using logistic regression analyses. Results The sensitivity for any prescription medication use was 0.57, ranging between 0.07 (dermatological corticosteroids) and 0.83 (antihypertensives) for medication groups, and between 0.00 (naproxen) and 0.73 (salbutamol) for individual medications. Overall, specificity was high (0.93-1.00). Smoking during pregnancy and completing the questionnaire >2 years after delivery were associated with increased disagreement between the questionnaire for prescription medication use and the reference standard. Conclusions The validity of the self-administered questionnaire for prescription medication use during pregnancy was moderate to poor for most medications and disagreement differed by some maternal characteristics. As many epidemiological studies use similar questionnaires to assess medication use these studies may need additional data sources such as pharmacy records or prescription databases for medication use next to self-reported methods. Also, previous knowledge on the effect of questionnaire design should be taken into account.
引用
收藏
页码:43 / 54
页数:12
相关论文
共 50 条
  • [41] Maternal Use of Antibiotics, Hospitalisation for Infection during Pregnancy, and Risk of Childhood Epilepsy: A Population-Based Cohort Study
    Norgaard, Mette
    Ehrenstein, Vera
    Nielsen, Rikke Beck
    Bakketeig, Leiv Sigmund
    Sorensen, Henrik Toft
    PLOS ONE, 2012, 7 (01):
  • [42] Association of maternal levothyroxine use during pregnancy with offspring birth and neurodevelopmental outcomes: a population-based cohort study
    Grace Mengqin Ge
    Edmund C. L. Cheung
    Kenneth K. C. Man
    Patrick Ip
    Wing Cheong Leung
    Gloria H. Y. Li
    Annie W. C. Kung
    Ching-Lung Cheung
    Ian C. K. Wong
    BMC Medicine, 20
  • [43] Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: A population-based study
    Sujan, Ayesha C.
    Quinn, Patrick D.
    Rickert, Martin E.
    Wiggs, Kelsey K.
    Lichtenstein, Paul
    Larsson, Henrik
    Almqvist, Catarina
    Oberg, A. Sara
    D'Onofrio, Brian M.
    PLOS MEDICINE, 2019, 16 (12)
  • [44] Is Maternal Use of Medicines during Pregnancy Associated with Deciduous Molar Hypomineralisation in the Offspring? A Prospective, Population-Based Study
    Elfrink, Marlies E. C.
    Moll, Henriette A.
    Kiefte-de Jong, Jessica C.
    El Marroun, Hanan
    Jaddoe, Vincent W. V.
    Hofman, Albert
    Stricker, Bruno H.
    ten Cate, Jacob M.
    Veerkamp, Jaap S. J.
    DRUG SAFETY, 2013, 36 (08) : 627 - 633
  • [45] Is Maternal Use of Medicines during Pregnancy Associated with Deciduous Molar Hypomineralisation in the Offspring? A Prospective, Population-Based Study
    Marlies E. C. Elfrink
    Henriette A. Moll
    Jessica C. Kiefte-de Jong
    Hanan El Marroun
    Vincent W. V. Jaddoe
    Albert Hofman
    Bruno H. Stricker
    Jacob M. ten Cate
    Jaap S. J. Veerkamp
    Drug Safety, 2013, 36 : 627 - 633
  • [46] Association of maternal levothyroxine use during pregnancy with offspring birth and neurodevelopmental outcomes: a population-based cohort study
    Ge, Grace Mengqin
    Cheung, Edmund C. L.
    Man, Kenneth K. C.
    Ip, Patrick
    Leung, Wing Cheong
    Li, Gloria H. Y.
    Kung, Annie W. C.
    Cheung, Ching-Lung
    Wong, Ian C. K.
    BMC MEDICINE, 2022, 20 (01)
  • [47] Maternal use of nitrosatable drugs during pregnancy and adult male reproductive health: A population-based cohort study
    Clemmensen, Pernille Jul
    Brix, Nis
    Schullehner, Jorg
    Toft, Gunnar
    Tottenborg, Sandra Sogaard
    Hougaard, Karin Sorig
    Bjerregaard, Anne Ahrendt
    Halldorsson, Thorhallur Ingi
    Olsen, Sjurdur Frodi
    Hansen, Birgitte
    Stayner, Leslie Thomas
    Sigsgaard, Torben
    Kolstad, Henrik
    Bonde, Jens Peter Ellekilde
    Ramlau-Hansen, Cecilia Host
    ANDROLOGY, 2024, 12 (08) : 1740 - 1750
  • [48] Prescription opioid use and concurrent psychotropic drug use during pregnancy: A population-based retrospective cohort study utilizing linked administrative data
    Chateau, Dan
    Singal, Deepa
    Hanlon-Dearman, Ana
    Ruth, Chelsea
    Katz, Laurence
    Brownell, Marni
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 181 - 181
  • [49] Association between hypertensive medication during pregnancy and risk of several maternal and neonatal outcomes in women with chronic hypertension: a population-based study
    Cantarutti, Anna
    Porcu, Gloria
    Locatelli, Anna
    Corrao, Giovanni
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (05) : 637 - 645
  • [50] Prescription medication use during pregnancies that resulted in births and abortions (2001-2013): A retrospective population-based study in a Canadian population
    Leong, Christine
    Chateau, Dan
    Dahl, Matthew
    Falk, Jamie
    Katz, Alan
    Bugden, Shawn
    Raymond, Colette
    PLOS ONE, 2019, 14 (03):